Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "EPS"

550 News Found

Eugia Pharma Specialities receives USFDA final approval for Posaconazole Injection
Drug Approval | December 27, 2023

Eugia Pharma Specialities receives USFDA final approval for Posaconazole Injection

The product is expected to be launched in December 2023


Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business
People | December 19, 2023

Sanofi India appoints Himanshu Bakshi as GM - Consumer Healthcare Business

His most recent stint was with Danone India as its Managing Director


WHO issues warning on the surge of new age gateway devices among children
Healthcare | December 14, 2023

WHO issues warning on the surge of new age gateway devices among children

Mothers Against Vaping also highlights a recent study of young people at risk of experiencing significant respiratory symptoms after just 30 days of electronic cigarette and other new age gateway products use


Fire accident at Parmax Pharma’s plant
News | December 09, 2023

Fire accident at Parmax Pharma’s plant

There has been no loss or injury to human life


Operations disrupted at NATCO Pharma's Manali, Chennai factory
News | December 08, 2023

Operations disrupted at NATCO Pharma's Manali, Chennai factory

NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises


Sulzer launches new biodegradable polymer
Packaging | December 04, 2023

Sulzer launches new biodegradable polymer

The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates


Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension
Drug Approval | December 01, 2023

Eugia Pharma receives USFDA approval for Budesonide Inhalation Suspension

The product is expected to be launched in FY25


BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement
Digitisation | November 28, 2023

BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement

First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease


GSK receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia
Drug Approval | November 21, 2023

GSK receives positive CHMP opinion recommending momelotinib for myelofibrosis patients with anaemia

Decision on EU marketing authorisation expected for momelotinib by early 2024